eFFECTOR Therapeutics, Inc. Annual Operating Lease, Payments in USD from 2020 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.
Summary
eFFECTOR Therapeutics, Inc. quarterly/annual Operating Lease, Payments history and growth rate from 2020 to 2023.
  • eFFECTOR Therapeutics, Inc. Operating Lease, Payments for the quarter ending March 31, 2024 was $19K, a 35.7% increase year-over-year.
  • eFFECTOR Therapeutics, Inc. Operating Lease, Payments for the twelve months ending March 31, 2024 was $105K, a 9.38% increase year-over-year.
  • eFFECTOR Therapeutics, Inc. annual Operating Lease, Payments for 2023 was $100K, unchanged from 2022.
  • eFFECTOR Therapeutics, Inc. annual Operating Lease, Payments for 2022 was $100K, unchanged from 2021.
  • eFFECTOR Therapeutics, Inc. annual Operating Lease, Payments for 2021 was $100K, a 85.7% decline from 2020.
Operating Lease, Payments, Trailing 12 Months (USD)
Operating Lease, Payments, Annual (USD)
Operating Lease, Payments, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $100K $0 0% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-26
2022 $100K $0 0% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-26
2021 $100K -$600K -85.7% Jan 1, 2021 Dec 31, 2021 10-K 2022-03-16
2020 $700K Jan 1, 2020 Dec 31, 2020 10-K 2022-03-16
* An asterisk sign (*) next to the value indicates that the value is likely invalid.